UK markets open in 3 hours 36 minutes
NIKKEI 225
26,369.24 +215.43 (+0.82%) HANG SENG
21,854.16 +23.81 (+0.11%) CRUDE OIL
110.22 +1.79 (+1.65%) GOLD FUTURES
1,810.70 +9.20 (+0.51%) DOW
31,097.26 +321.86 (+1.05%) BTC-GBP
16,684.45 +848.74 (+5.36%)
Sesen Bio, Inc. (SESN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.8104 |
| Open | 0.8200 |
| Bid | 0.7950 x 1200 |
| Ask | 0.8050 x 1800 |
| Day's range | 0.7811 - 0.8708 |
| 52-week range | 0.3650 - 6.0400 |
| Volume | |
| Avg. volume | 5,707,071 |
| Market cap | 159.352M |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 2.35 |
| EPS (TTM) | 0.3400 |
| Earnings date | 08 Aug 2022 - 12 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.78 |
- Zacks
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
The EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to AstraZeneca's (AZN) cancer drugs, Enhertu and Lynparza, for treating certain patients with breast cancer.
- Zacks
Kezar (KZR) Doubles on Promising Kidney Disorder Study Data
Shares of Kezar (KZR) surge more than 100% during after-hour trading on Jun 27, following a promising data readout from a mid-stage study evaluating zetomipzomib in patients with active lupus nephritis.
- Zacks
Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen
Ipsen, through its wholly-owned subsidiary, is set to acquire Epizyme (EPZM) for $1.45 per share, in cash, along with a contingent value right of $1 per share. The transaction is likely to close by third-quarter 2022.
© 2022 Yahoo. All rights reserved.
